Massive HIV database could unlock secrets of Long-Term health
NCT ID NCT03690063
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study follows a large group of people with HIV over many years to track their health, treatments, and any complications. Researchers will collect medical data during regular clinic visits to better understand how the disease and its treatments affect patients over time. The goal is to improve care and outcomes for people living with HIV.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal long-term trends in HIV management and complications, helping doctors improve care for people living with HIV.
- What could go wrong
- This is an observational study, not a treatment trial. It collects data but does not test a new drug or intervention, so it cannot directly lead to a cure or new therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 2,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 1996
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients HIV innocents of any treatment and recently infected
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Enrol consecutive patients with a scheduled visit in the outpatient clinic (regardless of CD4 cell count and ART status). Exclusion Criteria: \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Human immunodeficiency virus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHU de Nice
RECRUITINGNice, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tiny tweets, big impact? testing digital nudges to boost HIV prevention
- Can a phone app help young adults with HIV stay on track?
- Can a mouth rinse reveal hidden HPV risks in HIV patients?
- Could a single shot replace daily HIV pills?
- Walking groups could shield HIV-Positive latino men from heart disease
- Friends helping friends: a novel social-network strategy to boost HIV prevention